Treatment of postmenopausal osteoporotic women with parathyroid hormone 1-84 for 18 months increases cancellous bone formation and improves cancellous architecture: a study of iliac crest biopsies using histomorphometry and micro computed tomography

J Musculoskelet Neuronal Interact. 2005 Oct-Dec;5(4):356-7.

Authors

J Fox¹, M A Miller, R R Recker, S P Bare, S Y Smith, I Moreau

Affiliation

¹ NPS Pharmaceuticals, Salt Lake City, UT 84108, USA. [email protected]

PMID: 16340137

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Aged
Bone Development / drug effects*
Bone and Bones / drug effects
Bone and Bones / pathology*
Female
Humans
Ilium / pathology*
Middle Aged
Osteoporosis, Postmenopausal / drug therapy*
Osteoporosis, Postmenopausal / pathology*
Parathyroid Hormone / therapeutic use*
Tomography, X-Ray Computed

Substances

Parathyroid Hormone